CRISPR Therapeutics AG (CRSP)
55.61
-0.80
(-1.42%)
USD |
NASDAQ |
Apr 24, 16:00
55.60
-0.01
(-0.02%)
After-Hours: 18:25
CRISPR Therapeutics Price: 55.61 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 55.93 | 58.68 | 55.56 | 56.41 | 1.185M |
| Apr 22, 2024 | 55.40 | 56.93 | 54.37 | 55.66 | 1.044M |
| Apr 19, 2024 | 56.16 | 57.50 | 54.28 | 55.05 | 1.766M |
| Apr 18, 2024 | 55.86 | 58.03 | 55.25 | 56.16 | 1.745M |
| Apr 17, 2024 | 58.34 | 58.47 | 55.52 | 55.56 | 1.400M |
| Apr 16, 2024 | 58.04 | 58.74 | 57.14 | 57.96 | 1.177M |
| Apr 15, 2024 | 60.74 | 60.95 | 58.47 | 58.72 | 1.468M |
| Apr 12, 2024 | 62.23 | 62.35 | 60.25 | 60.67 | 1.079M |
| Apr 11, 2024 | 62.69 | 63.08 | 61.32 | 62.91 | 1.040M |
| Apr 10, 2024 | 62.10 | 62.93 | 60.31 | 61.74 | 1.981M |
| Apr 09, 2024 | 64.00 | 65.24 | 63.07 | 65.19 | 1.006M |
| Apr 08, 2024 | 63.21 | 64.22 | 62.51 | 64.09 | 1.124M |
| Apr 05, 2024 | 64.40 | 64.45 | 62.33 | 62.90 | 1.681M |
| Apr 04, 2024 | 64.83 | 67.25 | 64.67 | 65.06 | 1.221M |
| Apr 03, 2024 | 64.73 | 65.46 | 63.60 | 64.60 | 996091.0 |
| Apr 02, 2024 | 66.00 | 66.39 | 64.26 | 65.03 | 1.499M |
| Apr 01, 2024 | 68.14 | 68.39 | 66.50 | 68.18 | 1.078M |
| Mar 28, 2024 | 69.98 | 70.12 | 67.52 | 68.16 | 1.603M |
| Mar 27, 2024 | 71.49 | 71.54 | 68.88 | 70.16 | 1.341M |
| Mar 26, 2024 | 71.29 | 73.09 | 70.89 | 70.97 | 835997.0 |
| Mar 25, 2024 | 71.55 | 72.04 | 70.68 | 71.08 | 909468.0 |
| Mar 22, 2024 | 74.50 | 74.59 | 71.55 | 71.61 | 1.024M |
| Mar 21, 2024 | 73.78 | 75.91 | 73.18 | 74.50 | 1.486M |
| Mar 20, 2024 | 71.51 | 74.20 | 70.70 | 72.94 | 1.283M |
| Mar 19, 2024 | 71.09 | 72.66 | 70.36 | 71.96 | 1.295M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
33.68
Minimum
Mar 16 2020
210.04
Maximum
Jan 14 2021
74.06
Average
63.21
Median
Price Benchmarks
| Vertex Pharmaceuticals Inc | 400.73 |
| Intellia Therapeutics Inc | 21.17 |
| Novartis AG | 98.39 |
| Verve Therapeutics Inc | 6.595 |
| AC Immune SA | 2.36 |
Price Related Metrics
| Price to Book Value | 2.507 |
| Earnings Yield | -3.47% |
| Market Cap | 4.720B |